יום הסרטן הבין-לאומי

 

 

Session I

 

9:00 - 9:20 |  Prof. Dan Peer Tel-Aviv University

Therapeutic Genome Editing in Cancer ”

 

9:20 - 9:40 |  Prof. Dina Ben Yehuda Hadassah-Hebrew University School of Medicine 

“Targeted Livin-Nanoparticles  for Lymphoma Therapy”

 

9:40 - 10:00 |  Prof. Moshe Oren Weizmann Institute of science

"p53 mutations in cancer: sequence matters!”

 

10:00 - 10:20 |  Prof. Irit Ben-Aharon  Rambam Health Care Campus 

“COVID and cancer - the unsolved dilemma”

 

10:20 - 10:40 | Prof. Cyrille Cohen  Bar-Ilan University

“Enhancing the anti-tumor function of TCR/CAR engineered T-cells through the expression of chimeric switch receptors (CSR)”

 

 

Session II

 

11:00 - 11:20 |  Prof. Avi Schroeder Technion – Israel Institute of Technology

“Tumor origin and patient sex affect nano-medicine efficacy”

 

11:20 - 11:40 | Prof. Neta Erez Tel-Aviv University

“Stromal and immune plasticity shape the metastatic microenvironment“

 

11:40 - 12:00 | Prof. Eli Pikarsky  Hadassah Hebrew University Medical Center 

“Opposing roles of tertiary lymphoid structures in liver cancer”

 

12:00 - 12:20 | Prof. Ruth Scherz-Shouval Weizmann Institute of Science

“Mutation and stress dependencies in the tumor microenvironment”

 

12:20 - 12:40 | Prof. Gidi Rechavi Sheba Medical Center

“Cancer epitranscriptomics”